Ovl-gravitate-Alicia
type: Bundle
node role: treeRoot
id:
  v: Ovl-gravitate-Alicia
meta:
  profile:
    v: http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips
    l: Bundle-uv-ips
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: alicia-ips-1
type:
  v: document
timestamp:
  v: 2023-04-18T09:22:00+02:00
entry:
  full url:
    v: https://myserver.org/Composition/Ovl-alicia-comp
    l: Ovl-alicia-comp
  resource: Ovl-alicia-comp
entry:
  full url:
    v: https://myserver.org/Patient/Ovl-alicia-patient
    l: Ovl-alicia-patient
  resource: Ovl-alicia-patient
entry:
  full url:
    v: https://myserver.org/Practitioner/Ovl-alicia-pract
    l: Ovl-alicia-pract
  resource: Ovl-alicia-pract
entry:
  full url:
    v: https://myserver.org/Condition/Ovl-alicia-cond-1
    l: Ovl-alicia-cond-1
  resource: Ovl-alicia-cond-1
entry:
  full url:
    v: https://myserver.org/Condition/Ovl-alicia-cond-2
    l: Ovl-alicia-cond-2
  resource: Ovl-alicia-cond-2
entry:
  full url:
    v: https://myserver.org/Condition/Ovl-alicia-cond-3
    l: Ovl-alicia-cond-3
  resource: Ovl-alicia-cond-3
entry:
  full url:
    v: https://myserver.org/Condition/Ovl-alicia-cond-4
    l: Ovl-alicia-cond-4
  resource: Ovl-alicia-cond-4
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-1
    l: Ovl-alicia-med-stat-1
  resource: Ovl-alicia-med-stat-1
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-3
    l: Ovl-alicia-med-stat-3
  resource: Ovl-alicia-med-stat-3
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-4
    l: Ovl-alicia-med-stat-4
  resource: Ovl-alicia-med-stat-4
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-5
    l: Ovl-alicia-med-stat-5
  resource: Ovl-alicia-med-stat-5
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-6
    l: Ovl-alicia-med-stat-6
  resource: Ovl-alicia-med-stat-6
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-8
    l: Ovl-alicia-med-stat-8
  resource: Ovl-alicia-med-stat-8
entry:
  full url:
    v: https://myserver.org/MedicationStatement/Ovl-alicia-med-stat-added
    l: Ovl-alicia-med-stat-added
  resource: Ovl-alicia-med-stat-added
entry:
  full url:
    v: https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda78367
entry:
  full url:
    v: https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda79261
entry:
  full url:
    v: https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda7785h
    l: 6f4151e9-91f6-4f1e-adc3-fb94dda7785h
  resource: 6f4151e9-91f6-4f1e-adc3-fb94dda7785h
entry:
  full url:
    v: https://myserver.org/Medication/Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
    l: Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
  resource: Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
entry:
  full url:
    v: https://myserver.org/Medication/Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78356
entry:
  full url:
    v: https://myserver.org/Medication/Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78333
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-pregnancy
    l: Ovl-alicia-pregnancy
  resource: Ovl-alicia-pregnancy
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-bw
    l: Ovl-alicia-bw
  resource: Ovl-alicia-bw
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-bh
    l: Ovl-alicia-bh
  resource: Ovl-alicia-bh
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-bp
    l: Ovl-alicia-bp
  resource: Ovl-alicia-bp
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-glucose
    l: Ovl-alicia-glucose
  resource: Ovl-alicia-glucose
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-egfr
    l: Ovl-alicia-egfr
  resource: Ovl-alicia-egfr
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-potassium
    l: Ovl-alicia-potassium
  resource: Ovl-alicia-potassium
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-QR-EQ5D-5L
    l: Ovl-alicia-QR-EQ5D-5L
  resource: Ovl-alicia-QR-EQ5D-5L
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-Health-Literacy-YesNo
    l: Ovl-alicia-Health-Literacy-YesNo
  resource: Ovl-alicia-Health-Literacy-YesNo
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-Digital-Literacy-Scale
    l: Ovl-alicia-Digital-Literacy-Scale
  resource: Ovl-alicia-Digital-Literacy-Scale
entry:
  full url:
    v: https://myserver.org/Observation/Ovl-alicia-physical-activity
    l: Ovl-alicia-physical-activity
  resource: Ovl-alicia-physical-activity

Ovl-alicia-comp
type: Composition
id:
  v: gravitate-Alicia
text:
  status:
    v: extensions
  div:
    v: Id: gravitate-Alicia status: Final Type: Patient summary Document Subject: Alicia Gravitate Sections: Problem List Depression HIV Trigeminal neuralgia Overweight Medication Summary BIKTARVY Bictegravir/Emtricitabine/Tenofovir Alafenamide 1 t QD CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES Carbamazepine 1 t TID Orlistat 1 cp TID St. John’s Wort 2 cp BID Flucelvax Flucelvax
status:
  v: final
type:
  coding: https://loinc.org/rdf/60591-5
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 60591-5
    display:
      v: Patient summary Document
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
date:
  v: 2018-07-10T15:22:00+02:00
author:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
title:
  v: Patient Summary (Alicia Gravitate)
confidentiality:
  v: N
section:
  title:
    v: Problem List
  code:
    coding: https://loinc.org/rdf/11450-4
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 11450-4
      display:
        v: Problem list Reported
  entry:
    l: Ovl-alicia-cond-1
    reference:
      v: Condition/Ovl-alicia-cond-1
    display:
      v: Depression
  entry:
    l: Ovl-alicia-cond-2
    reference:
      v: Condition/Ovl-alicia-cond-2
    display:
      v: HIV
  entry:
    l: Ovl-alicia-cond-3
    reference:
      v: Condition/Ovl-alicia-cond-3
    display:
      v: Trigeminal neuralgia
  entry:
    l: Ovl-alicia-cond-4
    reference:
      v: Condition/Ovl-alicia-cond-4
    display:
      v: Overweight
section:
  title:
    v: Medication Summary
  code:
    coding: https://loinc.org/rdf/10160-0
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 10160-0
      display:
        v: Hx of Medication use
  text:
    status:
      v: additional
    div:
      v: Medication list Reported
  entry:
    l: Ovl-alicia-med-stat-1
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-1
    display:
      v: BIKTARVY Bictegravir/Emtricitabine/Tenofovir Alafenamide 1 t QD
  entry:
    l: Ovl-alicia-med-stat-3
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-3
    display:
      v: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
  entry:
    l: Ovl-alicia-med-stat-4
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-4
    display:
      v: Carbamazepine 1 t TID
  entry:
    l: Ovl-alicia-med-stat-5
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-5
    display:
      v: Orlistat 1 cp TID
  entry:
    l: Ovl-alicia-med-stat-6
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-6
    display:
      v: St. John’s Wort 2 cp BID
  entry:
    l: Ovl-alicia-med-stat-8
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-8
    display:
      v: Flucelvax
  entry:
    l: Ovl-alicia-med-stat-added
    reference:
      v: MedicationStatement/Ovl-alicia-med-stat-added
    display:
      v: Flucelvax

Ovl-alicia-patient
type: Patient
id:
  v: Ovl-alicia-patient
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Patient Ovl-alicia-patient Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) Active: true Other Id: keycloak-id/31297ad1-cb3c-4138-a132-e64016170e1d Patient Citizenship: code: Spain
extension:
  extension:
    url:
      v: code
      l: code
    value: CodeableConcept
  url:
    v: http://hl7.org/fhir/StructureDefinition/patient-citizenship
    l: patient-citizenship
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: alicia-1
identifier:
  system:
    v: keycloak-id
    l: keycloak-id
active:
  v: true
name:
  family:
    v: Gravitate
  given:
    v: Alicia
gender:
  v: female
birth date:
  v: 1998-10-05

Ovl-alicia-pract
type: Practitioner
id:
  v: Ovl-alicia-pract
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Practitioner Ovl-alicia-pract name: Walter Waltz
name:
  family:
    v: Waltz
  given:
    v: Walter
  prefix:
    v: Dr.

Ovl-alicia-cond-1
type: Condition
id:
  v: Ovl-alicia-cond-1
meta:
  profile:
    v: http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips
    l: Condition-uv-ips
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition Ovl-alicia-cond-1 Profile: Condition (IPS) clinicalStatus: Active code: Depressive disorder (disorder) subject: alicia Gravitate
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/35489007
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 35489007
    display:
      v: Depressive disorder (disorder)
  text:
    v: Depressive disorder (disorder)
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: alicia Gravitate

Ovl-alicia-cond-2
type: Condition
id:
  v: Ovl-alicia-cond-2
meta:
  profile:
    v: http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips
    l: Condition-uv-ips
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition Ovl-alicia-cond-2 Profile: Condition (IPS) clinicalStatus: Active code: Human immunodeficiency virus infection subject: alicia Gravitate onset: 2018 asserter: Dr. Walter Waltz
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/86406008
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 86406008
    display:
      v: Human immunodeficiency virus infection
  text:
    v: Human immunodeficiency virus infection
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: alicia Gravitate
onset: DateTime
  v: 2018
asserter:
  l: Ovl-alicia-pract
  reference:
    v: Practitioner/Ovl-alicia-pract
  display:
    v: Dr. Walter Waltz

Ovl-alicia-cond-3
type: Condition
id:
  v: Ovl-alicia-cond-3
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition Ovl-alicia-cond-3 clinicalStatus: Active code: Trigeminal neuralgia (disorder) subject: Identifier: https://www.gravitatehealth.eu/sid/doc/alicia-1 onset: 2018 asserter: Dr. Walter Waltz
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/31681005
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 31681005
    display:
      v: Trigeminal neuralgia (disorder)
  text:
    v: Trigeminal neuralgia (disorder)
subject:
  identifier:
    system:
      v: https://www.gravitatehealth.eu/sid/doc
      l: doc
    value:
      v: alicia-1
onset: DateTime
  v: 2018
asserter:
  l: Ovl-alicia-pract
  reference:
    v: Practitioner/Ovl-alicia-pract
  display:
    v: Dr. Walter Waltz

Ovl-alicia-cond-4
type: Condition
id:
  v: Ovl-alicia-cond-4
meta:
  profile:
    v: http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips
    l: Condition-uv-ips
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition Ovl-alicia-cond-4 Profile: Condition (IPS) clinicalStatus: Active code: Overweight (finding) subject: Alicia Gravitate onset: 2018 asserter: Dr. Walter Waltz
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/238131007
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 238131007
    display:
      v: Overweight (finding)
  text:
    v: Overweight (finding)
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
onset: DateTime
  v: 2018
asserter:
  l: Ovl-alicia-pract
  reference:
    v: Practitioner/Ovl-alicia-pract
  display:
    v: Dr. Walter Waltz

Ovl-alicia-med-stat-1
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-1
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-1 status: Active medication: BIKTARVY Bictegravir/Emtricitabine/Tenofovir Alafenamide 1 t QD subject: Alicia Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  l: Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
  reference:
    v: Medication/Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
  display:
    v: BIKTARVY Bictegravir/Emtricitabine/Tenofovir Alafenamide 1 t QD
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

Ovl-alicia-med-stat-3
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-3
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-3 status: Active medication: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES subject: Alicia Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  l: Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda7785h
  reference:
    v: Medication/Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda7785h
  display:
    v: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

Ovl-alicia-med-stat-4
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-4
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-4 status: Active medication: Carbamazepine 1 t TID subject: alicia Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  display:
    v: Carbamazepine 1 t TID
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

Ovl-alicia-med-stat-5
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-5
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-5 status: Active medication: Orlistat 1 cp TID subject: Alicia Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  display:
    v: Orlistat 1 cp TID
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

Ovl-alicia-med-stat-6
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-6
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-6 status: Active medication: St. John’s Wort 2 cp BID subject: Alicia Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  display:
    v: St. John’s Wort 2 cp BID
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

Ovl-alicia-med-stat-8
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-8
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-8 status: Active medication: Flucelvax subject: Alicia Gravitate Dosages - Route * Intramuscular use
status:
  v: active
medication: Reference
  display:
    v: Flucelvax
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20035000
      display:
        v: Intramuscular use

Ovl-alicia-med-stat-added
type: MedicationStatement
id:
  v: Ovl-alicia-med-stat-added
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement Ovl-alicia-med-stat-added status: Active medication: Remsima 100 mg powder for concentrate for solution for infusion subject: Alicia Gravitate informationSource: Alicia Gravitate Dosages - Route * Intravenous use
status:
  v: active
medication: Reference
  display:
    v: Remsima 100 mg powder for concentrate for solution for infusion
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
information source:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
  display:
    v: Alicia Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20045000
      display:
        v: Intravenous use

https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda78367
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication 6f4151e9-91f6-4f1e-adc3-fb94dda78367 code: Flucelvax form: suspension for injection in pre-filled syringe Ingredients - Item[x] Strength * INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE 15 mcg (Details: UCUM codemcg = 'mcg')/1 suspension for injection in pre-filled syringe (Details: standardterms.edqm.eu code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/18/1326/001
    display:
      v: Flucelvax
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xbb82cd10ab2add752b2b9224931000k2
    display:
      v: Flucelvax
  coding:
    system:
      v: http://www.whocc.no/atc
      l: atc
    code:
      v: A03ku92
    display:
      v: Flucelvax
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10219999
    display:
      v: suspension for injection in pre-filled syringe
  text:
    v: suspension for injection in pre-filled syringe
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: TU2UN5CG9C
      display:
        v: INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE
    text:
      v: INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE
  strength:
    numerator:
      value:
        v: 15
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mcg
    denominator:
      value:
        v: 1
      unit:
        v: suspension for injection in pre-filled syringe
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda79261
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication 6f4151e9-91f6-4f1e-adc3-fb94dda79261 code: HIPÉRICO ARKOPHARMA cápsulas duras form: Tablet Ingredients - Item[x] Strength * HYPERICUM PERFORATUM WHOLE 175 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: 79963
    display:
      v: HIPÉRICO ARKOPHARMA cápsulas duras
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xbb82cd10ab2add752b2b9224931099j1
    display:
      v: St. John's Wort (HIPÉRICO ARKOPHARMA) hard tablet
  coding:
    system:
      v: http://www.whocc.no/atc
      l: atc
    code:
      v: A03FA02
    display:
      v: HYPERICUM PERFORATUM WHOLE
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10219000
    display:
      v: Tablet
  text:
    v: Tablet
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: XK4IUX8MNB
      display:
        v: HYPERICUM PERFORATUM WHOLE
    text:
      v: HYPERICUM PERFORATUM WHOLE
  strength:
    numerator:
      value:
        v: 175
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

6f4151e9-91f6-4f1e-adc3-fb94dda7785h
type: Medication
id:
  v: 6f4151e9-91f6-4f1e-adc3-fb94dda7785h
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication 6f4151e9-91f6-4f1e-adc3-fb94dda7785h code: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES form: Effervescent tablet ingredient item: calcium carbonate strength: 1000 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet') ingredient item: cholecalciferol strength: 880 {UI} (Details: UCUM code{UI} = '{UI}')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: 68290
    display:
      v: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xF79CABF272B6A7EEF104DDDA44E82716
    display:
      v: Calcium Vitamin D
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10222000
    display:
      v: Effervescent tablet
  text:
    v: Effervescent tablet
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: H0G9379FGK
      display:
        v: Calcium carbonate
    text:
      v: calcium carbonate
  strength:
    numerator:
      value:
        v: 1000
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: 1C6V77QF41
      display:
        v: cholecalciferol
    text:
      v: cholecalciferol
  strength:
    numerator:
      value:
        v: 880
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: {UI}
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
type: Medication
id:
  v: Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication Ovl-9d7be868-8264-4d94-ad04-ef04ecc92i99 code: Biktarvy 30 mg/120 mg/15 mg film-coated tablets form: Coated tablet ingredient item: bictegravir strength: 30 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet') ingredient item: emtricitabine strength: 120 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet') ingredient item: tenofovir alafenamida strength: 15 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/18/1289/001
    display:
      v: Biktarvy 30 mg/120 mg/15 mg film-coated tablets
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0x073AF2E5B92AE19E8B67635AFFB3D9nq
    display:
      v: Biktarvy 30 mg/120 mg/15 mg film-coated tablets
  coding: http://snomed.info/id/774856007
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 774856007
    display:
      v: Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)
  coding:
    system:
      v: http://www.whocc.no/atc
      l: atc
    code:
      v: J05AR20
    display:
      v: emtricitabine, tenofovir alafenamide and bictegravir
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10220000
    display:
      v: Coated tablet
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: 8GB79LOJ07
      display:
        v: bictegravir
    text:
      v: bictegravir
  strength:
    numerator:
      value:
        v: 30
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: G70B4ETF4S
      display:
        v: emtricitabine
    text:
      v: emtricitabine
  strength:
    numerator:
      value:
        v: 120
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: EL9943AG5J
      display:
        v: tenofovir alafenamida
    text:
      v: tenofovir alafenamida
  strength:
    numerator:
      value:
        v: 15
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

https://myserver.org/Medication/Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78356
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78356 code: Tegretol (Carbamazepine) 200 mg tablets form: Tablet Ingredients - Item[x] Strength * CARBAMAZEPINE 200 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: 39.955
    display:
      v: Tegretol (Carbamazepine) 200 mg tablets
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0x6e5dd079852edc5c3b8efce075c80a2e
    display:
      v: Carbamazepine 200 mg tablets
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10219000
    display:
      v: Tablet
  text:
    v: Tablet
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: 33CM23913M
      display:
        v: CARBAMAZEPINE
    text:
      v: CARBAMAZEPINE
  strength:
    numerator:
      value:
        v: 200
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

https://myserver.org/Medication/Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78333
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication Ovl-6f4151e9-91f6-4f1e-adc3-fb94dda78333 code: Xenical (Orlistat) 60 mg capsule form: Capsule, hard Ingredients - Item[x] Strength * ORLISTAT 60 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: EDQM Standard Terms code15054000 = 'Tablet')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/98/071/004
    display:
      v: Xenical (Orlistat) 60 mg capsule
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xc805ef896d1c2f5f17f84f34c909a9db
    display:
      v: Xenical (Orlistat) 60 mg capsule
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10210000
    display:
      v: Capsule, hard
  text:
    v: Capsule, hard
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: 95M8R751W8
      display:
        v: ORLISTAT
    text:
      v: ORLISTAT
  strength:
    numerator:
      value:
        v: 60
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 15054000

Ovl-alicia-pregnancy
type: Observation
id:
  v: Ovl-alicia-pregnancy
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-pregnancy status: Final code: Pregnancy status subject: IPS 4 Gravitate effective: 2020-01-10 value: Pregnant
status:
  v: final
code:
  coding: https://loinc.org/rdf/82810-3
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 82810-3
    display:
      v: Pregnancy status
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2020-01-10
value: CodeableConcept
  coding: LA15173-0
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: LA15173-0
    display:
      v: Pregnant

Ovl-alicia-bw
type: Observation
id:
  v: Ovl-alicia-bw
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-bw status: Final category: Vital Signs code: Body weight subject: IPS 4 Gravitate effective: 2009-10-09 value: 70 kg (Details: UCUM codekg = 'kg')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/29463-7
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 29463-7
    display:
      v: Body weight
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
value: Quantity
  value:
    v: 70
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: kg

Ovl-alicia-bh
type: Observation
id:
  v: Ovl-alicia-bh
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-bh status: Final category: Vital Signs code: Body height subject: IPS 4 Gravitate effective: 2009-10-09 value: 170 cm (Details: UCUM codecm = 'cm')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/8302-2
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 8302-2
    display:
      v: Body height
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
value: Quantity
  value:
    v: 170
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: cm

Ovl-alicia-bp
type: Observation
id:
  v: Ovl-alicia-bp
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-bp status: Final category: Vital Signs code: Blood pressure panel with all children optional subject: IPS 4 Gravitate effective: 2009-10-09 component code: Diastolic blood pressure value: 80 mm[Hg] (Details: UCUM codemm[Hg] = 'mm[Hg]') component code: Systolic blood pressure value: 120 mm[Hg] (Details: UCUM codemm[Hg] = 'mm[Hg]')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/85354-9
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 85354-9
    display:
      v: Blood pressure panel with all children optional
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
component:
  code:
    coding: https://loinc.org/rdf/8462-4
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 8462-4
      display:
        v: Diastolic blood pressure
  value: Quantity
    value:
      v: 80
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mm[Hg]
component:
  code:
    coding: https://loinc.org/rdf/8480-6
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 8480-6
      display:
        v: Systolic blood pressure
  value: Quantity
    value:
      v: 120
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mm[Hg]

Ovl-alicia-glucose
type: Observation
id:
  v: Ovl-alicia-glucose
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-glucose status: Final category: Vital Signs code: Glucose [Moles/volume] in Blood subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2013-04-02 09:30:10+0100 value: 6.3 mmol/l (Details: UCUM codemmol/L = 'mmol/L') interpretation: High ReferenceRanges - Low High * 3.1 mmol/l (Details: UCUM codemmol/L = 'mmol/L') 6.2 mmol/l (Details: UCUM codemmol/L = 'mmol/L')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/15074-8
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 15074-8
    display:
      v: Glucose [Moles/volume] in Blood
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 6.3
  unit:
    v: mmol/l
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mmol/L
interpretation:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation
      l: v3-ObservationInterpretation
    code:
      v: H
    display:
      v: High
reference range:
  low:
    value:
      v: 3.1
    unit:
      v: mmol/l
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mmol/L
  high:
    value:
      v: 6.2
    unit:
      v: mmol/l
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mmol/L

Ovl-alicia-egfr
type: Observation
id:
  v: Ovl-alicia-egfr
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-egfr status: Final category: Vital Signs code: Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among black population subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2013-04-02 09:30:10+0100 value: 29 mL/min/1.73m2 (Details: UCUM codemL/min/1.73m2 = 'mL/min/1.73m2')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/48643-1
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 48643-1
    display:
      v: Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among black population
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 29
  unit:
    v: mL/min/1.73m2
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mL/min/1.73m2

Ovl-alicia-potassium
type: Observation
id:
  v: Ovl-alicia-potassium
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-potassium status: Final category: Vital Signs code: Potassium [Moles/volume] in Blood subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2013-04-02 09:30:10+0100 value: 2.5 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/6298-4
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 6298-4
    display:
      v: Potassium [Moles/volume] in Blood
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 2.5
  unit:
    v: mmol/L
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mmol/L

Ovl-alicia-QR-EQ5D-5L
type: QuestionnaireResponse
id:
  v: Ovl-alicia-QR-EQ5D-5L
text:
  status:
    v: generated
  div:
    v: Generated Narrative: QuestionnaireResponse Ovl-alicia-QR-EQ5D-5L LinkID Text Definition Answer<img src="[binary]" alt="doco" style="background-color: inherit"/> Ovl-alicia-QR-EQ5D-5L Questionnaire:EQ-5D-5L #xD; d1 EQ-5D-5L Levels: 2 (Slight problems) #xD; d2 EQ-5D-5L Levels: 1 (No problems) #xD; d3 EQ-5D-5L Levels: 3 (Moderate problems) #xD; d4 EQ-5D-5L Levels: 2 (Slight problems) #xD; d5 EQ-5D-5L Levels: 1 (No problems) #xD; vas 78 #xD; <img src="[binary]" alt="doco" style="background-color: inherit"/> Documentation for this format
questionnaire:
  v: http://hl7.eu/fhir/ig/gravitate-health-ips/Questionnaire/Questionnaire-EQ5D-5L
  l: Questionnaire-EQ5D-5L
status:
  v: completed
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
authored:
  v: 2025-10-08T10:35:00Z
item:
  link id:
    v: d1
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 2
      display:
        v: Slight problems
item:
  link id:
    v: d2
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 1
      display:
        v: No problems
item:
  link id:
    v: d3
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 3
      display:
        v: Moderate problems
item:
  link id:
    v: d4
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 2
      display:
        v: Slight problems
item:
  link id:
    v: d5
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 1
      display:
        v: No problems
item:
  link id:
    v: vas
  answer:
    value: Integer
      v: 78

Ovl-alicia-Health-Literacy-YesNo
type: Observation
id:
  v: Ovl-alicia-Health-Literacy-YesNo
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-Health-Literacy-YesNo status: Final category: Social History code: Health literacy (self-reported) subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2025-10-08 value: Yes
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: social-history
code:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: health-literacy
    display:
      v: Health literacy (self-reported)
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2025-10-08
value: CodeableConcept
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: yes
    display:
      v: Yes

Ovl-alicia-Digital-Literacy-Scale
type: Observation
id:
  v: Ovl-alicia-Digital-Literacy-Scale
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-Digital-Literacy-Scale status: Final category: Social History code: Digital literacy (self-reported) subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2025-10-08 value: 2 interpretation: Medium
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: social-history
code:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: digital-literacy
    display:
      v: Digital literacy (self-reported)
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2025-10-08
value: Integer
  v: 2
interpretation:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: medium
    display:
      v: Medium

Ovl-alicia-physical-activity
type: Observation
id:
  v: Ovl-alicia-physical-activity
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Ovl-alicia-physical-activity status: Final category: Activity code: Physical activity level subject: Alicia Gravitate Female, DoB: 1998-10-05 ( https://www.gravitatehealth.eu/sid/doc#alicia-1) effective: 2013-04-02 09:30:10+0100 value: Moderately active physical exercise level
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: activity
    display:
      v: Activity
code:
  coding: https://loinc.org/rdf/89555-7
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 89555-7
    display:
      v: Physical activity level
subject:
  l: Ovl-alicia-patient
  reference:
    v: Patient/Ovl-alicia-patient
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: CodeableConcept
  coding: http://snomed.info/id/228400000
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 228400000
    display:
      v: Moderately active physical exercise level

v: urn:iso:std:iso:3166
l: 3166

v: ES

v: Spain